Proteins that are expressed by both malignant and healthy fetal tissues are recognized as
oncofetal. These antigens are associated with cell proliferation and differentiation and are …

Tumor markers in gynecologic malignancies can be classified generally as oncofetal
proteins, carcinoplacental proteins, and more specific tumor‐associated antigens …

Background Recent insights provide support for the treatment of cancer during pregnancy, a
coincidence that poses both mother and fetus at risk. Our aim was to critically review studies …

Purpose Although cancer diagnosed during pregnancy is rare, the coexistence of pregnancy
and malignancy becomes more common in view of prolongation of reproductive age …

Serum tumour markers have had a role in screening, diagnosis and monitoring of some
gynaecological cancers. Women with suspected ovarian malignancies have as routine a …

OBJECTIVE: Our purpose was to establish reference values for six monoclonal antibody–
based serum immunoassays applied in patients with carcinoma of the female genital tract …

Ovarian, endometrial, and cervical cancers are three of the most common malignancies of
the female reproductive organs. CA 125, historically the most reliable serum marker for …

Plasma levels of carcinoembryonic antigen (CEA), alpha‐fetoprotein (AFP), and human
chorionic gonadotropin (hCG) were measured in 253 patients with gynecologic …

Plasma from 262 patients with gynecologic malignancies was assayed for levels of
circulating tumor markers (CA 125, LSA [lipid associated sialic acid in plasma, LASA‐P …

Objective: To evaluate the value of maternal serum CA125 and CA15-3 concentrations for
discriminating pathological from normal pregnancies. Methods: Serum samples from 120 …